Submitted by Anonymous (not verified) on 15 October 2025 - 13:20
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 3, Status: Authorised